ATE502636T1 - Topische zusammensetzungen mit telmestein zur behandlung von dermatologischen erkrankungen - Google Patents

Topische zusammensetzungen mit telmestein zur behandlung von dermatologischen erkrankungen

Info

Publication number
ATE502636T1
ATE502636T1 AT04790183T AT04790183T ATE502636T1 AT E502636 T1 ATE502636 T1 AT E502636T1 AT 04790183 T AT04790183 T AT 04790183T AT 04790183 T AT04790183 T AT 04790183T AT E502636 T1 ATE502636 T1 AT E502636T1
Authority
AT
Austria
Prior art keywords
topical compositions
dermatological diseases
telmestein
treatment
dermatitis
Prior art date
Application number
AT04790183T
Other languages
English (en)
Inventor
Marco Mastrodonato
Original Assignee
Sinclair Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sinclair Pharmaceuticals Ltd filed Critical Sinclair Pharmaceuticals Ltd
Application granted granted Critical
Publication of ATE502636T1 publication Critical patent/ATE502636T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/4261,3-Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/08Antiseborrheics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
AT04790183T 2003-10-09 2004-10-07 Topische zusammensetzungen mit telmestein zur behandlung von dermatologischen erkrankungen ATE502636T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001941A ITMI20031941A1 (it) 2003-10-09 2003-10-09 Composizioni farmaceutiche topiche per il trattamento delle dermatiti
PCT/EP2004/011228 WO2005037275A1 (en) 2003-10-09 2004-10-07 Topical compositions comprising telmesteine for treating dermatological disorders

Publications (1)

Publication Number Publication Date
ATE502636T1 true ATE502636T1 (de) 2011-04-15

Family

ID=34452248

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04790183T ATE502636T1 (de) 2003-10-09 2004-10-07 Topische zusammensetzungen mit telmestein zur behandlung von dermatologischen erkrankungen

Country Status (11)

Country Link
US (2) US20070213381A1 (de)
EP (1) EP1670464B1 (de)
JP (1) JP2007508264A (de)
CN (1) CN1863529A (de)
AT (1) ATE502636T1 (de)
AU (2) AU2004281521B2 (de)
BR (1) BRPI0415225A (de)
CA (1) CA2540859A1 (de)
DE (1) DE602004031964D1 (de)
IT (1) ITMI20031941A1 (de)
WO (1) WO2005037275A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2471135A (en) * 2009-06-19 2010-12-22 H D S Ltd Hair dye composition and use in reducing contact allergy
AU2010270797B2 (en) * 2009-07-08 2015-03-19 Dermira (Canada), Inc. TOFA analogs useful in treating dermatological disorders or conditions
US20120109042A1 (en) * 2010-10-28 2012-05-03 John Koo Methods of Treating Diseased Tissue
KR101670765B1 (ko) * 2014-09-19 2016-11-01 주식회사 명진뉴텍 글리신계 물질을 포함하는 방부조성물
LT3421093T (lt) 2017-06-27 2020-12-10 Daxxin AB Galvos odos ir plaukų plovimo priemonės arba odos plovimo priemonės, į kurių sudėtį įeina piroktono olaminas, skystoji kompozicija
WO2019006233A1 (en) 2017-06-30 2019-01-03 The Procter & Gamble Company HAIR CARE COMPOSITIONS COMPRISING 2-PYRIDINOL-N-OXIDE TYPE MATERIAL AND IRON CHELATOR
MX380728B (es) 2017-06-30 2025-03-12 Procter & Gamble Composiciones antitranspirantes y desodorantes
US10543164B2 (en) 2017-06-30 2020-01-28 The Procter & Gamble Company Deodorant compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0348541B1 (de) * 1988-06-29 1992-04-01 YASON S.r.l N-Karbethoxy-4-thiazolin-karbonsäure, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
CA2164955A1 (en) * 1993-06-18 1995-01-05 Richard J. Sharpe Method for treating hyperkeratosis and diseases mediated by proteases
ITMI20020756A1 (it) * 2002-04-09 2003-10-09 Sinclair Pharma S R L Composizioni farmaceutiche topiche per il trattamento delle dermatiti

Also Published As

Publication number Publication date
JP2007508264A (ja) 2007-04-05
CA2540859A1 (en) 2005-04-28
BRPI0415225A (pt) 2006-12-05
DE602004031964D1 (de) 2011-05-05
ITMI20031941A1 (it) 2005-04-10
WO2005037275A1 (en) 2005-04-28
US20070213381A1 (en) 2007-09-13
US8431601B2 (en) 2013-04-30
AU2004281521B2 (en) 2008-04-17
CN1863529A (zh) 2006-11-15
EP1670464A1 (de) 2006-06-21
EP1670464B1 (de) 2011-03-23
AU2004281521A1 (en) 2005-04-28
AU2008203101A1 (en) 2008-08-07
US20100130568A1 (en) 2010-05-27

Similar Documents

Publication Publication Date Title
SI1485080T1 (sl) Uporaba adapalena za zdravljenje dermatoloških motenj
DE60136348D1 (de) Topische zusammensetzung zur behandlung von psoriasis und verwandten hautkrankheiten
CY1108932T1 (el) Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων
JO2448B1 (en) Topical pharmaceutical compositions for the treatment of dermatitis
WO2006120682A3 (en) Compositions and methods for treating hyperproliferative epidermal diseases
BRPI0407662B8 (pt) derivados do ácido 1-fenilalcanocarboxílico para o tratamento de doenças neurodegenerativas
ATE516037T1 (de) Topische formulierung von ivermectin zur behandlung von dermatologischen erkrankungen
MX344787B (es) Composiciones que contienen berberina o analogos de la misma para tratar rosacea o trastornos de la piel relacionados con enrojecimiento de la cara.
WO2003092617A3 (en) Combinations for the treatment of inflammatory skin disorders
ATE441423T1 (de) Verwendung von mastix und dessen ätherischen ílen zur verhinderung oder bekämpfung von mikrobieller infektionen
DE602004017871D1 (de) Zubereitungen zur behandlung von arthritischen erscheinungen
DE60231050D1 (de) Verwendung von Totarol zur Behandlung von Pruritus
WO2007046097A3 (en) Topical compositions for the treatment of depilation-induced skin irritation or prevention thereof
ATE502636T1 (de) Topische zusammensetzungen mit telmestein zur behandlung von dermatologischen erkrankungen
TW200517137A (en) Method for decreasing sebum production
DK1343472T3 (da) Thixotropisk næsespray
MX2023010918A (es) Metodos y composiciones para el tratamiento de enfermedades oculares.
DE60027127D1 (de) Verwendung von Polyaminosäurederivaten zur Behandlung von Seborrhoe und verwandten Hautstörungen
DK1893237T3 (da) Farmaceutisk sammensætning, der omfatter en organopolysiloxan ela-stomer og et solubiliseret aktivt stof
WO2009036751A3 (de) Kosmetische oder dermatologische zusammensetzung zur topischen verwendung
ATE516028T1 (de) Zusammensetzung zur behandlung von hauterkrankungen
US9757326B2 (en) Hair rejuvenating lotion
WO2024173581A3 (en) Formulations for the treatment of skin diseases and conditions
ATE444071T1 (de) Pharmazeutische zusammensetzungen zur behandlung von hauterkrankungen
WO2010000686A2 (en) Composition for topical use

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties